Decision: Supplemental Examination No. 96/000,096
Holding: Some reexamined claims canceled, other amended claims survived. The surviving claims remain in doubt in view of a later covered business method review (CBM) proceeding.
Background: Under the America Invents Act (“AIA”), supplemental examinations allow
On July 15, 2019, the U.S. Patent and Trademark Office (USPTO) released an update of certain sections of the Trial Practice Guide, providing further guidance on the rules governing AIA trial proceedings, also known as Patent Trial and Appeal Board
On July 15, 2019, the U.S. Patent and Trademark Office (USPTO) released an update of certain sections of the Trial Practice Guide, providing further guidance on the rules governing AIA trial proceedings, also known as Patent Trial and Appeal Board
On July 15, 2019, the U.S. Patent and Trademark Office (USPTO) released an update of certain sections of the Trial Practice Guide, providing further guidance on the rules governing AIA trial proceedings, also known as Patent Trial and Appeal Board
On July 15, 2019, the U.S. Patent and Trademark Office (USPTO) released an update of certain sections of the Trial Practice Guide, providing further guidance on the rules governing AIA trial proceedings, also known as Patent Trial and Appeal Board
Decision: Supplemental Examination No. 96/000,128Read more
Manual of Patent Examining and Procedure (MPEP) § 2106.
Under these guidelines, assessing a claim’s eligibility involved three steps. First, the Office considers whether the claim covers a statutory category of processes, machines, manufactures, or compositions of matter. If so, the
May was a relatively good month for patent owners at the PTAB. The Patent Trial and Appeal Board issued 49 IPR and CBM Final Written Decisions, including decisions following remands from the Federal Circuit, cancelling 475 (67.95%) instituted claims while
May was a relatively good month for patent owners at the PTAB. The Patent Trial and Appeal Board issued 49 IPR and CBM Final Written Decisions, including decisions following remands from the Federal Circuit, cancelling 475 (67.95%) instituted claims while
